These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24433095)

  • 1. (64)Cu-labeled LyP-1-dendrimer for PET-CT imaging of atherosclerotic plaque.
    Seo JW; Baek H; Mahakian LM; Kusunose J; Hamzah J; Ruoslahti E; Ferrara KW
    Bioconjug Chem; 2014 Feb; 25(2):231-9. PubMed ID: 24433095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient mice.
    Hamzah J; Kotamraju VR; Seo JW; Agemy L; Fogal V; Mahakian LM; Peters D; Roth L; Gagnon MK; Ferrara KW; Ruoslahti E
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7154-9. PubMed ID: 21482787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of early stage atherosclerotic plaques using PET and CT fusion imaging targeting P-selectin in low density lipoprotein receptor-deficient mice.
    Nakamura I; Hasegawa K; Wada Y; Hirase T; Node K; Watanabe Y
    Biochem Biophys Res Commun; 2013 Mar; 433(1):47-51. PubMed ID: 23485468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 64Cu-Labeled Divalent Cystine Knot Peptide for Imaging Carotid Atherosclerotic Plaques.
    Jiang L; Tu Y; Kimura RH; Habte F; Chen H; Cheng K; Shi H; Gambhir SS; Cheng Z
    J Nucl Med; 2015 Jun; 56(6):939-44. PubMed ID: 25908832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.
    Pérez-Medina C; Binderup T; Lobatto ME; Tang J; Calcagno C; Giesen L; Wessel CH; Witjes J; Ishino S; Baxter S; Zhao Y; Ramachandran S; Eldib M; Sánchez-Gaytán BL; Robson PM; Bini J; Granada JF; Fish KM; Stroes ES; Duivenvoorden R; Tsimikas S; Lewis JS; Reiner T; Fuster V; Kjær A; Fisher EA; Fayad ZA; Mulder WJ
    JACC Cardiovasc Imaging; 2016 Aug; 9(8):950-61. PubMed ID: 27236528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/CT imaging of chemokine receptor CCR5 in vascular injury model using targeted nanoparticle.
    Luehmann HP; Pressly ED; Detering L; Wang C; Pierce R; Woodard PK; Gropler RJ; Hawker CJ; Liu Y
    J Nucl Med; 2014 Apr; 55(4):629-34. PubMed ID: 24591489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LyP-1-Modified Multifunctional Dendrimers for Targeted Antitumor and Antimetastasis Therapy.
    Song N; Zhao L; Xu X; Zhu M; Liu C; Sun N; Yang J; Shi X; Zhao J
    ACS Appl Mater Interfaces; 2020 Mar; 12(11):12395-12406. PubMed ID: 32077680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice.
    Laitinen I; Saraste A; Weidl E; Poethko T; Weber AW; Nekolla SG; Leppänen P; Ylä-Herttuala S; Hölzlwimmer G; Walch A; Esposito I; Wester HJ; Knuuti J; Schwaiger M
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):331-8. PubMed ID: 19808614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules.
    Qi S; Hoppmann S; Xu Y; Cheng Z
    Mol Imaging Biol; 2019 Oct; 21(5):907-916. PubMed ID: 30617730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Modular Construction of a Polymeric Nanoparticle for Targeted Atherosclerosis Positron Emission Tomography Imaging: A Story of 25% (64)Cu-CANF-Comb.
    Woodard PK; Liu Y; Pressly ED; Luehmann HP; Detering L; Sultan DE; Laforest R; McGrath AJ; Gropler RJ; Hawker CJ
    Pharm Res; 2016 Oct; 33(10):2400-10. PubMed ID: 27286872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CC Chemokine Receptor 5 Targeted Nanoparticles Imaging the Progression and Regression of Atherosclerosis Using Positron Emission Tomography/Computed Tomography.
    Detering L; Abdilla A; Luehmann HP; Williams JW; Huang LH; Sultan D; Elvington A; Heo GS; Woodard PK; Gropler RJ; Randolph GJ; Hawker CJ; Liu Y
    Mol Pharm; 2021 Mar; 18(3):1386-1396. PubMed ID: 33591187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis.
    Nahrendorf M; Keliher E; Panizzi P; Zhang H; Hembrador S; Figueiredo JL; Aikawa E; Kelly K; Libby P; Weissleder R
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1213-22. PubMed ID: 19833312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/CT Imaging of Chemokine Receptors in Inflammatory Atherosclerosis Using Targeted Nanoparticles.
    Luehmann HP; Detering L; Fors BP; Pressly ED; Woodard PK; Randolph GJ; Gropler RJ; Hawker CJ; Liu Y
    J Nucl Med; 2016 Jul; 57(7):1124-9. PubMed ID: 26795285
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Wei X; Liu Z; Zhao Z
    Hell J Nucl Med; 2019; 22(1):78-79. PubMed ID: 30968863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of a
    Jadvar H; Chen K; Park R; Yap LP; Vorobyova I; Swenson S; Markland FS
    Amino Acids; 2019 Nov; 51(10-12):1569-1575. PubMed ID: 31621030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of an
    Park JY; Kim HJ; Chae JR; Cho YL; Kang WJ
    Biochem Biophys Res Commun; 2024 Apr; 703():149650. PubMed ID: 38377941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of hypoxia in mouse atherosclerotic plaques with (64)Cu-ATSM.
    Nie X; Randolph GJ; Elvington A; Bandara N; Zheleznyak A; Gropler RJ; Woodard PK; Lapi SE
    Nucl Med Biol; 2016 Sep; 43(9):534-542. PubMed ID: 27372286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography/computed tomographic and magnetic resonance imaging in a murine model of progressive atherosclerosis using (64)Cu-labeled glycoprotein VI-Fc.
    Bigalke B; Phinikaridou A; Andia ME; Cooper MS; Schuster A; Schönberger T; Griessinger CM; Wurster T; Onthank D; Ungerer M; Gawaz M; Nagel E; Botnar RM
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):957-64. PubMed ID: 24107491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET/CT and MR imaging biomarker of lipid-rich plaques using [64Cu]-labeled scavenger receptor (CD68-Fc).
    Bigalke B; Phinikaridou A; Andia ME; Cooper MS; Schuster A; Wurster T; Onthank D; Münch G; Blower P; Gawaz M; Nagel E; Botnar RM
    Int J Cardiol; 2014 Nov; 177(1):287-91. PubMed ID: 25499394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.